Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Camptothecin, identified by CAS number 7689-03-4, stands as a pivotal compound in the ongoing battle against cancer. Originally isolated from the Camptotheca acuminata tree, this plant alkaloid has demonstrated remarkable efficacy as a DNA topoisomerase I inhibitor. This action is fundamental to its ability to halt cancer cell proliferation and induce programmed cell death, or apoptosis. The detailed research into camptothecin's role in apoptosis induction reveals its significant impact on cellular mechanisms.
The primary mechanism of Camptothecin involves stabilizing the complex formed between DNA and topoisomerase I. This stabilization prevents the re-ligation of DNA strands after they have been cut by the enzyme, leading to an accumulation of DNA breaks. These breaks ultimately trigger a cellular cascade that results in cell death, a critical factor in treating cancers. Understanding the intricacies of DNA topoisomerase I inhibition mechanisms is crucial for developing more effective cancer treatments.
The potency of Camptothecin against a wide spectrum of cancer cell lines, including various types of leukemia, lung, breast, and colon cancers, has driven extensive research. Studies on the anticancer activity of Camptothecin against various cancer cell lines have consistently shown its effectiveness. However, the original formulation of Camptothecin presented challenges due to its poor water solubility and certain adverse effects, prompting the development of various analogues.
The medicinal chemistry efforts have led to the creation of successful Camptothecin derivatives, such as topotecan and irinotecan. These analogues retain the core mechanism of action while offering improved pharmacokinetic profiles, including better solubility and reduced toxicity, making them viable options for clinical cancer chemotherapy. The ongoing research into these camptothecin analogues continues to expand therapeutic possibilities.
For researchers and pharmaceutical developers, Camptothecin (CAS 7689-03-4) remains a valuable tool. Its well-defined mechanism and extensive biological activity profile make it an excellent candidate for further studies in cancer cell biology research and the design of next-generation anticancer agents. The continuous exploration of its derivatives and delivery systems promises to enhance its therapeutic impact.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
